您当前所在的位置:首页 > 产品中心 > 产品详细信息
565460-15-3 分子结构
点击图片或这里关闭

cyclohexyl N-(3-phenylphenyl)carbamate

ChemBase编号:130096
分子式:C19H21NO2
平均质量:295.37554
单一同位素质量:295.15722892
SMILES和InChIs

SMILES:
O=C(OC1CCCCC1)Nc1cccc(c1)c1ccccc1
Canonical SMILES:
O=C(Nc1cccc(c1)c1ccccc1)OC1CCCCC1
InChI:
InChI=1S/C19H21NO2/c21-19(22-18-12-5-2-6-13-18)20-17-11-7-10-16(14-17)15-8-3-1-4-9-15/h1,3-4,7-11,14,18H,2,5-6,12-13H2,(H,20,21)
InChIKey:
HHVUFQYJOSFTEH-UHFFFAOYSA-N

引用这个纪录

CBID:130096 http://www.chembase.cn/molecule-130096.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
cyclohexyl N-(3-phenylphenyl)carbamate
IUPAC传统名
cyclohexyl N-(3-phenylphenyl)carbamate
别名
Biphenyl-3-yl Carbamic Acid, Cyclohexyl Ester
N-[1,1'-Biphenyl]-3-yl-carbamic Acid Cyclohexyl Ester
[1,1'-Biphenyl]-3-yl-carbamic acid
cyclohexyl ester
URB602
[1,1’-Biphenyl]-3-yl-carbamic acid cyclohexyl ester
URB602
CAS号
565460-15-3
MDL号
MFCD08457914
PubChem SID
162224381
PubChem CID
10979337
CHEMBL
77767
Chemspider ID
9154538
维基百科标题
URB602

数据来源

数据来源

所有数据来源 商品来源 非商品来源

理论计算性质

理论计算性质

JChem
Acid pKa 12.972227  质子受体
质子供体 LogD (pH = 5.5) 5.2767434 
LogD (pH = 7.4) 5.276742  Log P 5.2767434 
摩尔折射率 88.695 cm3 极化性 35.370617 Å3
极化表面积 38.33 Å2 可自由旋转的化学键
里宾斯基五规则 false 

分子性质

分子性质

理化性质 安全信息 产品相关信息 生物活性(PubChem)
溶解度
DMSO expand 查看数据来源
DMSO: >10 mg/mL expand 查看数据来源
外观
Crystalline solid expand 查看数据来源
Off-White Solid expand 查看数据来源
white to off-white powder expand 查看数据来源
熔点
122-123°C expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
3 expand 查看数据来源
个人保护装置
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand 查看数据来源
保存温度
2-8°C expand 查看数据来源
纯度
≥98% (HPLC) expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
Empirical Formula (Hill Notation)
C19H21NO2 expand 查看数据来源

详细说明

详细说明

Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich TRC TRC
Sigma Aldrich -  U3010 external link
Biochem/physiol Actions
URB602 is an inhibitor of monoacylglycerol lipase (MGL). The IC50 = 28 μM and Km = 20 μM. URB602 increases 2-arachidonoylglycerol (2-AG) concentrations. When URB602 is injected into the periaqueductal grey matter, it enhances stress-induced analgesia (tail-flick test) in a CB1-dependent manner. An effect that is prevented by a CB1 cannabinoid receptor antagonist, Rimonabant (SR141716). URB602 is not suitable for systemic administration due to relatively low potency, but useful for research of pain and stress-related disorders, which identifies MGL as a previously unrecognized therapeutic target (highlighted in Chemical Engineering News, June 27, 2005).
Toronto Research Chemicals -  U821925 external link
URB602 is a selective inhibitor of MGL, exhibiting an IC50 of 28 μM for the rat brain enzyme. It does not inhibit fatty acid amide hydrolase (FAAH) at concentrations up to 100 μM, or other lipid metabolizing enzymes such as diacylglycerol lipase or cyclooxygenase-2.5 6 Inhibition of 2-AG hydrolysis is associated with enhanced stress-induced analgesia and may represent a novel drug target in pain and stress management.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Hohmann, A.G., et al.: Nature, 435, 1108 (2005)
  • Suplita, R.L., et al.: Neuropharmacol., Nov. 25 (epub), (2005)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle